6.
Rossi F, Amadoro C, Gasperi M, Colavita G
. Lactobacilli Infection Case Reports in the Last Three Years and Safety Implications. Nutrients. 2022; 14(6).
PMC: 8954171.
DOI: 10.3390/nu14061178.
View
7.
Liccardo D, Cannavo A, Spagnuolo G, Ferrara N, Cittadini A, Rengo C
. Periodontal Disease: A Risk Factor for Diabetes and Cardiovascular Disease. Int J Mol Sci. 2019; 20(6).
PMC: 6470716.
DOI: 10.3390/ijms20061414.
View
8.
Ziebolz D, Jahn C, Pegel J, Semper-Pinnecke E, Mausberg R, Waldmann-Beushausen R
. Periodontal bacteria DNA findings in human cardiac tissue - Is there a link of periodontitis to heart valve disease?. Int J Cardiol. 2017; 251:74-79.
DOI: 10.1016/j.ijcard.2017.09.001.
View
9.
Sandstedt J, Vukusic K, Rekabdar E, Dellgren G, Jeppsson A, Mattsson Hulten L
. Markedly reduced myocardial expression of γ-protocadherins and long non-coding RNAs in patients with heart disease. Int J Cardiol. 2021; 344:149-159.
DOI: 10.1016/j.ijcard.2021.09.046.
View
10.
Riad A, Jager S, Sobirey M, Escher F, Yaulema-Riss A, Westermann D
. Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice. J Immunol. 2008; 180(10):6954-61.
DOI: 10.4049/jimmunol.180.10.6954.
View
11.
Maeda H, Zhu X, Omura K, Suzuki S, Kitamura S
. Effects of an exopolysaccharide (kefiran) on lipids, blood pressure, blood glucose, and constipation. Biofactors. 2005; 22(1-4):197-200.
DOI: 10.1002/biof.5520220141.
View
12.
Rajendhran J, Shankar M, Dinakaran V, Rathinavel A, Gunasekaran P
. Contrasting circulating microbiome in cardiovascular disease patients and healthy individuals. Int J Cardiol. 2013; 168(5):5118-20.
DOI: 10.1016/j.ijcard.2013.07.232.
View
13.
Koren O, Spor A, Felin J, Fak F, Stombaugh J, Tremaroli V
. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci U S A. 2010; 108 Suppl 1:4592-8.
PMC: 3063583.
DOI: 10.1073/pnas.1011383107.
View
14.
de Oliveira C, Watt R, Hamer M
. Toothbrushing, inflammation, and risk of cardiovascular disease: results from Scottish Health Survey. BMJ. 2010; 340:c2451.
PMC: 2877809.
DOI: 10.1136/bmj.c2451.
View
15.
Miyake K
. Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors. Semin Immunol. 2007; 19(1):3-10.
DOI: 10.1016/j.smim.2006.12.002.
View
16.
Azevedo P, Polegato B, Minicucci M, Paiva S, Zornoff L
. Cardiac Remodeling: Concepts, Clinical Impact, Pathophysiological Mechanisms and Pharmacologic Treatment. Arq Bras Cardiol. 2015; 106(1):62-9.
PMC: 4728597.
DOI: 10.5935/abc.20160005.
View
17.
Emoto T, Yamashita T, Sasaki N, Hirota Y, Hayashi T, So A
. Analysis of Gut Microbiota in Coronary Artery Disease Patients: a Possible Link between Gut Microbiota and Coronary Artery Disease. J Atheroscler Thromb. 2016; 23(8):908-21.
PMC: 7399299.
DOI: 10.5551/jat.32672.
View
18.
Grazioli-Gauthier L, Rigamonti E, Leo L, Lucchini G, Lo Priore E, Bernasconi E
. Lactobacillus jensenii mitral valve endocarditis: Case report, literature review and new perspectives. IDCases. 2022; 27:e01401.
PMC: 8777067.
DOI: 10.1016/j.idcr.2022.e01401.
View
19.
Yoo J, Groer M, Dutra S, Sarkar A, McSkimming D
. Gut Microbiota and Immune System Interactions. Microorganisms. 2020; 8(10).
PMC: 7602490.
DOI: 10.3390/microorganisms8101587.
View
20.
Kumar H, Kawai T, Akira S
. Pathogen recognition in the innate immune response. Biochem J. 2009; 420(1):1-16.
DOI: 10.1042/BJ20090272.
View